Usbi Ventures Private Limited
About Usbi Ventures Private Limited
Data last updated:
Usbi Ventures Private Limited is a private limited company based in Ernakulam, Kerala, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 03 April 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U51909KL2019PTC057482.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Mymoonath Abdul Kasim (Managing Director) and Panattil Abdul Khadar Abdul Assis.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 68/1389 – A Mumtaz P.H Road Kacheripady, Ernakulam, Kerala, India – 682018.
As per the financials filed for FY 2025, the company reported a revenue of ₹80.37 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹57.35 Lakh (net margin 71.4%) and EBITDA of ₹57.35 Lakh (EBITDA margin 71.4%). Revenue has grown at a compounded annual rate (CAGR) of 62% over three years and 22% over five years.
Company details
Contact details
Usbi Ventures Private Limited's registered office is in Ernakulam, Kerala. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address68/1389 – A Mumtaz P.H Road Kacheripady, Ernakulam, Kerala, India – 682018
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Usbi Ventures Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Usbi Ventures is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
Financials of Usbi Ventures Private Limited
FY 2024 filings availableUsbi Ventures Private Limited reported revenue of ₹80.37 Lakh (up 194% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 22% over five years, including 194% growth in the latest year. EBITDA rose 698% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹57.35 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹57.35 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 71.4% | ||||
| Net Profit Margin | 71.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Usbi Ventures Private Limited, buy the company report.
Board of directors of Usbi Ventures Private Limited
Usbi Ventures has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Panattil Abdul Khadar Abdul Assis | Director | 03 Apr 2019 | 7 Years 6 Months | Current |
| Mymoonath Abdul Kasim | Managing Director | 20 Jan 2025 | 1 Years 9 Months | Current |
| Muhammad Peedikayilakath Also directs: Rainbow Publishers Private Limited, Budget B Mart Private Limited | Director | 19 Apr 2019 | 7 Years 6 Months | Current |
Peer comparison
Usbi Ventures Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Soyuz Healthcare Private Limited | ₹80.75 Lakh (FY 2018) | 482.0% | Delhi, India | |||
| JSBM Pharma Private Limited | ₹80.69 Lakh (FY 2025) | 182.0% | Indore, Madhya Pradesh, India | |||
| Cypress Pharmaceuticals Private Limited | ₹80.44 Lakh (FY 2020) | -84.0% | Mumbai, Maharashtra, India | |||
| Usbi Ventures Private Limitedthis company | ₹80.37 Lakh (FY 2025) | ₹57.35 Lakh | 71.4% | 194.0% | Ernakulam, Kerala, India | |
| Drashti Packaging Private Limited | ₹80.32 Lakh (FY 2025) | 13.0% | Rajkot, Gujarat, India | |||
| Remedy Cure India Limited | ₹80.18 Lakh (FY 2024) | 1.0% | New Delhi, Delhi, India | |||
| Logimed Pharma Private Limited | ₹80.17 Lakh (FY 2024) | -6.0% | Manimajra, Chandigarh, India | |||
| Lessac Research Laboratories Private Limited | ₹80.16 Lakh (FY 2023) | -30.0% | Puducherry, India |
To see the full peer comparison of Usbi Ventures Private Limited, buy the company report.
Auditor
Usbi Ventures Private Limited is audited by M/s. A P J M V & Associates LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M/s. A P J M V & Associates LLP | FY 2023 | 200086 |
Shareholding
The shareholding of Usbi Ventures Private Limited is on record for 4 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Usbi Ventures Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Usbi Ventures Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Usbi Ventures Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Usbi Ventures Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Usbi Ventures Private Limited has 9 board changes on record since 2019: 3 appointments and 6 cessations. The latest: Panattil Abdul Khadar Abdul Assis ceased to be Director on 26 Aug 2025.
Frequently asked questions
Usbi Ventures is an active private limited company based in Ernakulam, Kerala, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 03 April 2019 (7+ years old) and is registered under CIN U51909KL2019PTC057482.
Usbi Ventures has 3 current directors:
- Mymoonath Abdul Kasim - Managing Director
- Panattil Abdul Khadar Abdul Assis - Director
- Muhammad Peedikayilakath - Director
The latest financial statements of Usbi Ventures on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2020 are in the company report.
The CIN (Corporate Identification Number) of Usbi Ventures is U51909KL2019PTC057482. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Usbi Ventures was incorporated on 03 April 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Usbi Ventures by revenue are Soyuz Healthcare Private Limited, JSBM Pharma Private Limited, Cypress Pharmaceuticals Private Limited, Drashti Packaging Private Limited, Remedy Cure India Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Panattil Abdul Khadar Abdul Assis ceased to be Director on 26 Aug 2025. Mymoonath Abdul Kasim was appointed as Managing Director on 20 Jan 2025. Muhammad Peedikayilakath ceased to be Additional Director on 31 Dec 2020. Usbi Ventures has 9 board changes on record in total.
The registered office of Usbi Ventures is at 681389 – A Mumtaz P.H Road Kacheripady, Ernakulam, Kerala, India – 682018.
Usbi Ventures operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Usbi Ventures can be reached at its registered office: 681389 – A Mumtaz P.H Road Kacheripady, Ernakulam, Kerala, India – 682018.
Usbi Ventures is registered under the jurisdiction of the Registrar of Companies (ROC), Ernakulam.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
